Consonance Capital Partners, L.P. is a New York-based private equity manager focused exclusively. Organization, location and related investors we track.
Consonance Capital Partners, L.P. is a New York-based private equity manager focused exclusively on healthcare, founded by Mitchell Blutt, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle after more than a decade together at JPMorgan Partners and related entities. Its investing thesis centers on lower and middle market U.S. healthcare companies, with transactions spanning growth equity, leveraged buyouts, carve-outs, recapitalizations, and special situations. Public materials emphasize an emphasis on efficiency, cost containment, and high-quality care, but I could not verify a consistent disclosed check size or clear lead-versus-follow pattern from the available sources. Named portfolio companies referenced in public sources include Bako Integrated Physician Solutions and Enclara Pharmacia, and another source also cites Oliver Ops Blocker LLC as a holding. The firm says it has raised over $1.3 billion across two funds and was then investing out of Consonance Private Equity II, L.P.. Publicly available summaries also note the firm’s founders as principal owners and describe it as an active ESG investor. No distinctive public writing or repeated authored viewpoint was clearly
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Consonance Capital Partners, L.P. · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide